Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model
Open accessPublished version of a preprint
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Severe cases of SARS-CoV-2 infection are characterized by hypercoagulopathies and systemic endotheliitis of the lung microvasculature. The dynamics of vascular damage, and whether it is a direct consequence of endothelial infection or an indirect consequence of an immune cell-mediated cytokine storm remain unknown. Using a vascularized lung-on-chip model, we find that infection of alveolar epithelial cells leads to limited apical release of virions, consistent with reports of monoculture infection. However, viral RNA and proteins are rapidly detected in underlying endothelial cells, which are themselves refractory to apical infection in monocultures. Although endothelial infection is unproductive, it leads to the formation of cell clusters with low CD31 expression, a progressive loss of barrier integrity and a pro-coagulatory microenvironment. Viral RNA persists in individual cells generating an inflammatory response, which is transient in epithelial cells but persistent in endothelial cells and typified by IL-6 secretion even in the absence of immune cells. Inhibition of IL-6 signalling with tocilizumab reduces but does not prevent loss of barrier integrity. SARS-CoV-2-mediated endothelial cell damage thus occurs independently of cytokine storm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 1×
“On the other hand, infection resulted in increased expression of the TMPRSS2 protease (Hoffmann et al, 2020) required to cleave the spike protein for viral entry at 1 dpi in both cell types relative to uninfected controls (Fig 1F and I), with variable expression levels across chips.”
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613 · cited 2×
“Autopsy reports show numerous microvascular thrombi in the lungs of deceased patients together with evidence of the intracellular presence of the virus in vascular cells (Ackermann et al, 2020; Carsana et al, 2020).”
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046 · cited 10×
“No IL-6 was detected in the vascular effluent from uninfected controls.”
InfluentialReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“The epithelial face was incubated with epithelial base medium with 1 µ M dexamethasone (Sigma-Aldrich) without FBS supplementation to promote tight junction formation and surfactant expression as reported in previous lung-on-chip studies(Huh et al, 2010; Hassell et al, 2017).”
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · cited 5×
“Similarly, most infections of alveolar epithelial cells are usually performed at high MOI (Blanco-Melo et al, 2020).”
InfluentialBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · cited 1×
“Organ-on-chip technologies recreate key aspects of human physiology in a bottom-up and modular manner (Bhatia & Ingber, 2014).”
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · cited 1×
“We observed that low levels of intracellular viral RNA generate an NF-KB-mediated pro-inflammatory response, with suppression of antiviral interferon responses, consistent with reports of the effect of a number of viral proteins (Hadjadj et al, 2020; Thoms et al, 2020).”
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · cited 1×
“…in replication kinetics can also be appreciated from the fact that whereas the N gene is most abundant during productive infection in Vero E6 cells (Kim et al, 2020), The detection of SARS-CoV-2 genomes in the endothelial layer within 1 dpi suggests rapid dissemination through basolateral transfer…”
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122 · cited 4×
“Notably, NRP1 is likely to be located along the basal surface of the endothelial cells as an integrin-binding protein (Valdembri et al, 2009), and SARS-CoV-2 has been shown to infect vascularized organoids, albeit at high MOI (Monteil et al, 2020).”
InfluentialNeuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925 · cited 1×
“Neuropilin-1 (NRP1), an integrin-binding protein (Valdembri et al, 2009), has recently been reported to be an alternative receptor for SARS-CoV-2 entry (Cantuti-Castelvetri et al, 2020; Daly et al, 2020) that is highly expressed in pulmonary microvascular cells.”
Cited by
Items 101–141 of 141
Fisher, C. R., Medie, F. M., Luu, R. J., Quezada, L. A. L., Gaibler, R. B., Mulhern, T. J., Rubio, L. D., Marr, E. E., Gabriel, E. P., Borenstein, J. T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.07.495101 · Cited by 4
Yadav, S., Fujimoto, K., Takenaga, T., Takahashi, S., Muramoto, Y., Mikawa, R., Noda, T., Gotoh, S., & Yokokawa, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.24.568532 · Cited by 4
Hu, Z., Xu, Y.-E., Li, J. M., Wang, Y., Song, H. Y., & Ao, D.-S. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00290g · Cited by 3
Experimental dissection of tuberculosis protective immunity: a human perspective
Schmidiger, S., & Portevin, D. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1595076 · Cited by 3
Path dependency and the rescuing of the biomedical research enterprise
Nahle, Z. A. (2026) · Frontiers in Medical Technology · doi:10.3389/fmedt.2025.1683835 · Cited by 3
Lung-on-a-Chip Models of the Lung Parenchyma
Zamprogno, P., Schulte, J., Ferrari, D., Rechberger, K. F., Sengupta, A., van Os, L., Weber, T., Zeinali, S., Geiser, T., & Guenat, O. T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-26625-6_10 · Cited by 4
Muramatsu, F., Hosoe, N., Suzuki, T., Shimamura, T., Hayashi, Y., Takara, K., Lynda, L., Shimizu, A., Jia, W., Noda, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-06569-7 · Cited by 3
“In addition, infection of cultured vascular endothelial cells with SARS-CoV-2 has been reported to disrupt vascular endothelial cell junctions 31 .”
Brain organoids for addressing COVID-19 challenge
Yu, J. S., Wang, K., & Zheng, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1055601 · Cited by 3
“The model is widely used, especially in alveolar epithelial cells, endothelial cells, fluid, air-fluid interface, and air sac structures on both sides that deform with respiratory movements together constitute the lung organ- on-a-chip, and then infection with the COVID-19 can better simulate the virus transmission pr…”
Ni, K., Che, B., Yang, C., Qin, Y., Gu, R., Wang, C., Luo, M., & Deng, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033043 · Cited by 3
Lu, R. X. Z., Zhao, Y., & Radisic, M. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10581 · Cited by 3
“These systems provided insights into the mechanisms through which SARS-CoV-2 induces dysfunction in various organs, including the lung, 25-28 intestine, 29,30 and brain.”
BackgroundExposure-on-a-chip as a model for inhalation toxicology and pharmacology research
de la Serna, J. B., Ali, N., Liu, X., Katsouli, J., Chen, Y., Yan, C., Paramio, P., & Joseph, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00018-8 · Cited by 3
Mancini, L., Saliekh, L., Claydon, R., Kotar, J., Bényei, É. B., Munro, C. A., Shendruk, T. N., Brown, A. T., Welch, M., & Cicuta, P. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf279 · Cited by 3
“Organoids and infection-on-chip systems that encompass host tissues strike a compromise, improving imaging to the detriment of the immune response, which tends to be only partial [46–51].”
Microfluidic engineering of immune-competent organs-on-chips and their applications
Liang, X., Bu, X., Yuan, S., Wu, C., Liu, D., & Deng, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1743806 · Cited by 5
“The platform has also been used to model in fl uenza and bacterial infections, demonstrating that breathing motions enhance pathogen uptake and promote neutrophil and monocyte recruitment across the endothelium (28, 89, 90).”
Rindchen, A., Schneider‐Daum, N., & Lehr, C. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115917 · Cited by 3
Tissue-Engineered Three-Dimensional Platforms for Disease Modeling and Therapeutic Development
Wheeler, E. E., & Leach, J. K. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0212 · Cited by 5
“159 Both in vitro and in vivo results indicate that epithelial and endothelial cells can be directly infected by SARS-CoV-2.”
Fonseca, B. F., Wong-Ng, J., Connor, M. G., Mary, H., Kim, M. H., Yim, R., Bondet, V., Michel, V., Strick‐Marchand, H., Santo, J. P. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.31.644992 · Cited by 4
“SARS-CoV-2 effects have been widely investigated in airway and alveolar-like in vitro systems such as reconstructed airway epithelia in transwells 5,30,56–58 , organoids 10,39,57,59 and organ-on-chip models 45,60,61 .”
Air-blood barrier (ABB) on a chip
Fu, A., Chang, M., Zhu, H., Liu, H., Wu, D., & Zeng, H. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.116919 · Cited by 3
The endothelium at the crossroads of multi-organ pathology: Insights from organ-on-chip models
Ghosh, S., Shukla, P. C., & Das, S. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107551 · Cited by 3
Faley, S. L., Boghdeh, N. A., Schaffer, D. K., Spivey, E. C., Alem, F., Narayanan, A., Wikswo, J. P., & Brown, J. A. (2025) · Lab on a Chip · doi:10.1039/d5lc00510h · Cited by 1
Application and prospects of lung organ-on-a-chip in the development of new drugs
Su, J., Qiu, J., Meng, J., Gong, Y., Xu, Y., & Han, J. (2025) · BioMedical Engineering OnLine · doi:10.1186/s12938-025-01497-z · Cited by 2
García-Mouton, C., Mishra, R., Collada, A., Hoos, M., Sharma, K., Nass, T., Sommer, M., Pérez‐Gil, J., & Thacker, V. V. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag197 · Cited by 1
Self-citationRespiratory Organ‐on‐a‐Chip for Disease Modeling: From Architecture to Functional Integration
Hu, J., Tang, Y., Liu, S., Xu, T., & Liu, Q. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505908 · Cited by 2
Advances in virus-host interaction research based on microfluidic platforms
Wang, C., Wang, J., Liu, D., & Zhang, Z. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110302 · Cited by 1
Tissue chips as headway model and incitement technology
Modi, P. S., Singh, A., Chaturvedi, A., Agarwal, S., Dutta, R., Nayak, R., & Singh, A. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.08.007 · Cited by 2
“These drugs have been evaluated for their efficacy in inhibiting viral replication, reducing inflammatory response, and potential viral entry inhibition in the context of SARS-CoV2 infection [66 – 68].”
BackgroundKiener, M., Maddalena, L. L. D., Roldán, N., Chouvardas, P., Froment, L., Menna, M. D., Geiser, T., Stucki, J. D., Hobi, N., & Julio, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.17.683096 · Cited by 1
“Finally, they identified IL-6 secretion as a driver of the deleterious inflammatory response and suggested tocilizumab, a neutralizing antibody to IL-6 receptor (IL-6R), as a potential drug candidate to reduce damage to the alveolar barrier 39 .”
Development of a cost-effective Alveolus-on-Chip for studying Mycobacterium tuberculosis infectionPreprint
Deboosère, N., Dagan, Y., Burette, A., Delannoy, E., Salomé‐Desnoulez, S., Werkmeister, E., Siméone, R., Brodin, P. M., & Grassart, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.29.721656 · Cited by 1
γδ T cells in 3D culture: The potential use in the therapeutics development
Wang, S., Lee, T., Kuo, C., Lai, Y., & Li, C. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.75
Meeting report – Cell dynamics: host–pathogen interface
Odendall, C., Sá‐Pessoa, J., & Mesquita, F. S. (2022) · Journal of Cell Science · doi:10.1242/jcs.260456
“Leveraging this model, this approach uncovered key mechanisms in endothelial cells that are responsible for the exacerbated immune responses associated with severe SARSCoV-2 illness (Thacker et al., 2021).”
Methodvan der Does, A. M., Guenat, O. T., Geiser, T., & Hiemstra, P. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90871-9.00001-2 · Cited by 1
Lung microphysiological system for predicting antiviral drug efficacy for COVID-19
Medie, F. M., Kim, H., Fisher, C. R., Haroutunian, N. J., & Borenstein, J. T. (2025) · The Microbe · doi:10.1016/j.microb.2025.100594
In Vitro Models for Emerging Infectious Disease Detection and Host–Pathogen Interaction Studies
Ezrari, S., Ikken, A., Grari, O., Ouzine, M., Lahmer, M., Saddari, A., & Maleb, A. (2026) · Applied Microbiology · doi:10.3390/applmicrobiol6010010 · Cited by 1
“OOC systems have also provided insights into SARS-CoV-2 pathophysiology, demonstrating rapid viral detection in endothelial cells normally resistant in 2D monocultures [128].”
Shan, Z., Li, J., Ye, Z., Chen, Y., Chen, J., Chen, Y., Wang, X., Gao, C., Jiang, S., & Zhang, N. (2026) · Virologica Sinica · doi:10.1016/j.virs.2026.02.002 · Cited by 1
“Notably, this vascular injury was independent of cytokine storms, and the inhibitory effect of tocilizumab was limited (Thacker et al., 2021).”
The organoid revolution to assess mycobacterial pulmonary infections
Leon‐Icaza, S. A. (2022) · theses.fr (ABES) · doi:10.70675/6e135d5fzb953z4ffcz9041z2684784040ad
Bang, I. J., Kim, M.-S., Han, Y., Kim, G. E., Lim, J. E., Park, J. Y., Yoo, J., Jang, Y. S., 이, 범., Kwak, M., et al. (2026) · Toxicological Research · doi:10.1007/s43188-026-00372-w · Cited by 1
“At multiplicities of infection (MOI) ranging from 0.01 to 1, SARS-CoV-2 infects ACE2 ⁺ epithelial cells within the chip, inducing cytopathic effects, junctional disruption, and cytokine storm-like secretions of IL-6, IL-8, and IFN-γ [204, 205].”
InfluentialAdvancing immunity research with immune-integrated organ-on-a-chip technologies
Ozefe, F., Körükcü, K. İ., & Tekin, H. C. (2026) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2026.100830
Immunoids: Building immunocompetent organoids from human pluripotent stem cells
O’Hern, C., Miller, Z., Dionise, M., Kulkarni, S., Contag, C. H., & Aguirre, A. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.016
Jalil, A. T., Mohammed, M. K., & Hindi, N. K. K. (2026) · In vitro models · doi:10.1007/s44164-026-00155-5
Li, X., Li, Y., Xu, J., Sun, R., Liu, W., Chen, X., Zhu, L., Zhao, Q., Li, J., Li, Y., et al. (2026) · Biosensors · doi:10.3390/bios16100547
“More recent work has shifted toward immune integration by incorporating macrophages, neutrophils, monocytes, and, in some cases, lymphocytes into chip-based lung models [23,24].”
Li, B., & Zhao, L. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103396
Lung-on-chip: engineering advances and application
Surendran, V., Leach, T. S., Blackburn, J., & Murphy, S. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00006-6
Blood vessels-on-a-chip chapter
Moya, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00015-7
Metadata
- Authors
- Thacker, V. V., Sharma, K., Dhar, N., Mancini, G.-F., Sordet-Dessimoz, J., & McKinney, J. D.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Thacker, Vivek V
- Sharma, Kunal
- Dhar, Neeraj
- Venue
- The EMBO Reports
- Published
- 2021-05-27
- Volume
- 22
- Issue
- 6
- Pages
- e52744-e52744
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC8183417
- OpenAlex
- W3159931117
- Cited by
- 142
- References
- 81
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 17 · 2023: 30 · 2022: 36 · 2021: 16
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Novartis Foundation for Medical-Biological Research ((#20C240))
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030B_176397)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- SARS-CoV-2, endothelial inflammation, vascular injury, lung-on-a-chip, endothelial cell infection, alveolar epithelial cells, hypercoagulability, interleukin-6, tocilizumab, endothelial barrier integrity, viral RNA persistence, cytokine storm, COVID-19 pandemic
- MeSH terms
- Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Lung, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.